# Drug Interactions When DA-8010 is Co-administered With Paroxetine or Mirabegron in Healthy Adults

> **NCT05992428** · PHASE1 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 37 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DA-8010 5mg
- **DRUG:** Paroxetine 20mg
- **DRUG:** Mirabegron 50mg

## Key facts

- **NCT ID:** NCT05992428
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-22
- **Primary completion:** 2023-11-07
- **Final completion:** 2023-12-05
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2024-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05992428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05992428, "Drug Interactions When DA-8010 is Co-administered With Paroxetine or Mirabegron in Healthy Adults". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05992428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*